Holding within the firm crossed the 5 per cent mark on November 7, 2022. The acquisition of shares was carried out at a mean worth of Rs 3,379.01, LIC mentioned in a regulatory submitting.
As a regulatory disclosure norm, listed corporations are required to tell the inventory exchanges upon change in shareholding to the tune of 5 per cent and above.
Divis Laboratories is engaged in manufacturing of Active Pharmaceutical Ingredients (APIs), intermediates and nutraceutical components with predominance in exports.
Inventory of LIC closed at Rs 631.20 apiece on BSE, down by 0.33 per cent, whereas Divis Lab scrip ended 3.38 per cent decrease at Rs 3,298.15